US Markets
Home›US Markets›Equities›Eli Lilly stock climbs as it gains ground in weight-lo…
Eli Lilly stock climbs as it gains ground in weight-loss rivals
Eli Lilly shares were up 3.4% to $1,223.04, according to the latest market snapshot in the story.
Eli Lilly shares were higher on the day, rising to $1,223.04, up $39.88 or 3.37%, as the stock erased Novo Nordisk’s early lead in weight-loss pill development progress.
The article frames Lilly’s move as part of a broader momentum shift in the weight-loss drug race, while noting the stock was rebounding from its 50-day trend level and trading above its shorter-term 21-day and 10-day lines.
The piece also presents Lilly’s latest valuation and trading performance in the context of its market action, showing the stock’s 12% gain referenced alongside the day’s increase.
← Newer storyChip stocks tumble in broad reversal after Monday gainsOlder story →Putin meets Myanmar leader, discusses oil refinery and LNG supply
More like this
US MarketsNasdaq slides as chipmakers sell off